drugset / Trial / NCT00881400
To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
To demonstrate the relative bioavailability of Cefzil 250 mg/5 ml oral suspension fed conditions.
Timeline
- Start
- 2004-06
- Primary completion
- 2004-06
- Completion
- 2004-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CEFPROZIL ANHYDROUS, (E)- | Small molecule | 10 ml | Oral |
Indications
No indication recorded.